PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Inclusion Criteria: * Adequate english to participate in focus groups and workshops without an interpreter * Patients of the study site who are currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months * Patients willing to participate in at least 60-minute and ideally 90-minute workshops at the designated study location, time and date. * Patients capable of providing informed consent before attending the first workshop For carers * Should be the primary carer nominated by a patient who fulfils the inclusion criteria, this includes parents of affected children * Should be willing to participate in at least a 60-minute and ideally 90-minute workshops at the designated study location, time and date. * Carers can only participate in the study with the cancer patient he/she is caring for. The patient has to also involved in the study * Carers need to be capable of providing informed consent before attending the first workshop For healthcare professionals * All clinicians need to be current employees of the study site * Doctors need to be employed at Specialist Registrar, Fellow or Consultant Level * Nurses of all grades are invited to participate but ideally need to have had some involvement in the outpatient care of oncology patients All participants:- * Should be willing to have the session's recorded audio, transcripts and analysed data from the focus groups/workshops shared with Entia Ltd. * should be willing to attend multiple 60 to 90 minute workshops. * should be willing for photos and video footage to be taken during the interview. * Participants attending workshops later in the development process must be comfortable consenting to finger prick testing/ assessing the ease of use of the test disposable Exclusion Criteria: For patients * Does not have adequate English to participate in focus group interview without an interpreter * Patients of the study site who are not currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months * Patients not willing to participate in at least 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date. * Participant not capable of providing consent or have a suitable, legally acceptable representative present to provide consent before the focus group interview. For carers * Is not the nominated primary carer of a cancer patient who fulfils the inclusion criteria, this includes parents of affected children * Not paired with a patient that is involved in the study * Carers not willing to participate in at least a 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date. For healthcare professionals ● Doctors who are not employed at Specialist Registrar, Fellow or Consultant Level